Clopidogrel versus ticlopidine after intracoronary stent placement

Peter B. Berger, Malcolm R. Bell, Charanjit S. Rihal, Henry Ting, Gregory Barsness, Kirk Garratt, Victoria Bellot, Verghese Mathew, Steve Melby, Lavon Hammes, Diane Grill, David R. Holmes

Research output: Contribution to journalArticle

150 Scopus citations

Abstract

OBJECTIVES: The study compared the safety and efficacy of ticlopidine with clopidogrel in patients receiving coronary stents. BACKGROUND: Stent thrombosis is reduced when ticlopidine is administered with aspirin. Clopidogrel is similar to ticlopidine in chemical structure and function but has fewer side effects; few data are available about its use in stent patients. METHODS: We compared 30-day event rates in 500 consecutive coronary stent patients treated with aspirin and clopidogrel (300 mg loading dose immediately prior to stent placement, and 75 mg/day for 14 days) to 827 consecutive stent patients treated with aspirin and ticlopidine (500 mg loading dose and 250 mg twice daily for 14 days). RESULTS: Patients treated with clopidogrel had more adverse clinical characteristics including older age, more severe angina, and more frequent infarction within the prior 24 h. Nonetheless, mortality was 0.4% in clopidogrel patients versus 1.1% in ticlopidine patients; nonfatal myocardial infarction occurred in 0% versus 0.5%, stent thrombosis in 0.2% versus 0.7%, bypass surgery or repeat angioplasty in 0.4% versus 0.5%, and any event occurred in 0.8% versus 1.6% of patients, respectively (p = NS). Based on the observed 30-day event rate of 1.6% with ticlopidine, the statistical power of the study was 43% to detect an even rate of 0.5% with clopidogrel, and 75% to detect an event rate with of 4% with clopidogrel, with a p value of 0.05. CONCLUSIONS: These data indicate that clopidogrel can be safely substituted for ticlopidine in patients receiving coronary stents.

Original languageEnglish (US)
Pages (from-to)1891-1894
Number of pages4
JournalJournal of the American College of Cardiology
Volume34
Issue number7
DOIs
StatePublished - Dec 1 1999

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Clopidogrel versus ticlopidine after intracoronary stent placement'. Together they form a unique fingerprint.

  • Cite this

    Berger, P. B., Bell, M. R., Rihal, C. S., Ting, H., Barsness, G., Garratt, K., Bellot, V., Mathew, V., Melby, S., Hammes, L., Grill, D., & Holmes, D. R. (1999). Clopidogrel versus ticlopidine after intracoronary stent placement. Journal of the American College of Cardiology, 34(7), 1891-1894. https://doi.org/10.1016/S0735-1097(99)00442-8